These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36880537)

  • 1. New SAMD9L heterozygous mutation leading to myelodysplastic syndrome and acute myeloid leukemia: A case report and review of the literature.
    Monagel DA
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1797. PubMed ID: 36880537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations.
    Ahmed IA; Farooqi MS; Vander Lugt MT; Boklan J; Rose M; Friehling ED; Triplett B; Lieuw K; Saldana BD; Smith CM; Schwartz JR; Goyal RK
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2186-2196. PubMed ID: 31306780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
    Davidsson J; Puschmann A; Tedgård U; Bryder D; Nilsson L; Cammenga J
    Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-function
    Tesi B; Davidsson J; Voss M; Rahikkala E; Holmes TD; Chiang SCC; Komulainen-Ebrahim J; Gorcenco S; Rundberg Nilsson A; Ripperger T; Kokkonen H; Bryder D; Fioretos T; Henter JI; Möttönen M; Niinimäki R; Nilsson L; Pronk CJ; Puschmann A; Qian H; Uusimaa J; Moilanen J; Tedgård U; Cammenga J; Bryceson YT
    Blood; 2017 Apr; 129(16):2266-2279. PubMed ID: 28202457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal Elimination of the Pathogenic Allele as Diagnostic Pitfall in
    Eggermann K; Meyer R; Begemann M; Dey D; Bültmann E; Kurth I; Korenke GC; Knopp C
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.
    Wong JC; Bryant V; Lamprecht T; Ma J; Walsh M; Schwartz J; Del Pilar Alzamora M; Mullighan CG; Loh ML; Ribeiro R; Downing JR; Carroll WL; Davis J; Gold S; Rogers PC; Israels S; Yanofsky R; Shannon K; Klco JM
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome.
    Cammenga J
    Exp Hematol; 2024 Jun; 134():104217. PubMed ID: 38649131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between SAMD9/SAMD9L and hematological malignancies].
    Narumi S; Hasegawa T
    Rinsho Ketsueki; 2018; 59(11):2475-2480. PubMed ID: 30531146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAMD9L autoinflammatory or ataxia pancytopenia disease mutations activate cell-autonomous translational repression.
    Russell AJ; Gray PE; Ziegler JB; Kim YJ; Smith S; Sewell WA; Goodnow CC
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of MIRAGE syndrome.
    Narumi S
    Pediatr Int; 2022 Jan; 64(1):e15283. PubMed ID: 35972063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutional
    Pastor VB; Sahoo SS; Boklan J; Schwabe GC; Saribeyoglu E; Strahm B; Lebrecht D; Voss M; Bryceson YT; Erlacher M; Ehninger G; Niewisch M; Schlegelberger B; Baumann I; Achermann JC; Shimamura A; Hochrein J; Tedgård U; Nilsson L; Hasle H; Boerries M; Busch H; Niemeyer CM; Wlodarski MW
    Haematologica; 2018 Mar; 103(3):427-437. PubMed ID: 29217778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.
    Chen DH; Below JE; Shimamura A; Keel SB; Matsushita M; Wolff J; Sul Y; Bonkowski E; Castella M; Taniguchi T; Nickerson D; Papayannopoulou T; Bird TD; Raskind WH
    Am J Hum Genet; 2016 Jun; 98(6):1146-1158. PubMed ID: 27259050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
    Sahoo SS; Kozyra EJ; Wlodarski MW
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
    Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
    Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathy.
    Vaughan D; Bogdanova-Mihaylova P; Costello DJ; Sweeney BJ; McNamara B; Walsh RA; Murphy SM
    J Peripher Nerv Syst; 2020 Dec; 25(4):433-437. PubMed ID: 32808377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance.
    Fernandez-Pol S; Ma L; Ohgami RS; Arber DA
    Mod Pathol; 2016 Sep; 29(9):996-1003. PubMed ID: 27255165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.
    Yoshida M; Tanase-Nakao K; Shima H; Shirai R; Yoshida K; Osumi T; Deguchi T; Mori M; Arakawa Y; Takagi M; Miyamura T; Sakaguchi K; Toyoda H; Ishida H; Sakata N; Imamura T; Kawahara Y; Morimoto A; Koike T; Yagasaki H; Ito S; Tomizawa D; Kiyokawa N; Narumi S; Kato M
    Br J Haematol; 2020 Dec; 191(5):835-843. PubMed ID: 32770553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predisposition and progression of myelodysplastic syndromes].
    Makishima H
    Rinsho Ketsueki; 2021; 62(4):278-288. PubMed ID: 33967153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline SAMD9L truncation variants trigger global translational repression.
    Allenspach EJ; Soveg F; Finn LS; So L; Gorman JA; Rosen ABI; Skoda-Smith S; Wheeler MM; Barrow KA; Rich LM; Debley JS; Bamshad MJ; Nickerson DA; Savan R; Torgerson TR; Rawlings DJ
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33724365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.